Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Michael Naso, Janssen to Present at Antibody & Protein Therapeutics Manufacturing on October 24-25 in San Diego, California - Michael Naso, Associate Director at Janssen R&D, will give a presentation titled “The Amazing Biology of the Cell: New Biological Concepts Leading to Novel Therapeutic Opportunities”
Michael Naso, Janssen to Present at Antibody & Protein Therapeutics Manufacturing on October 24-25 in San Diego, California

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2013/09/30 - Michael Naso, Associate Director at Janssen R&D, will give a presentation titled “The Amazing Biology of the Cell: New Biological Concepts Leading to Novel Therapeutic Opportunities”.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Michael Naso, Associate Director at Janssen R&D, will give a presentation titled “The Amazing Biology of the Cell: New Biological Concepts Leading to Novel Therapeutic Opportunities” at GTC’s Antibody & Protein Therapeutics Conference on October 24 25, 2013 in San Diego, CA

In his presentation, Dr. Naso will explain how cells are extremely dynamic entities, with many activities on-going at the same time that define the homeostatic cellular state. If perturbed, there can be rapid alterations to these activities with changes in gene expression that accompany fluctuations in chromatin structure in a dynamic nucleus. As a result of this dynamic complexity, there is a poor understanding of what drives cellular biology. The plasma cell membrane represents the main communication point between the cell and the external environment, possessing a diverse array of different protein receptors and accessory proteins that allow the cell to adjust to any changes presented to it externally. However, it just is being learned that there are many different ways these receptors transmit their signals inside the cell and how the cell integrates these signals to generate the cellular response. This response can be beneficial to the organism, or, detrimental, and result in disease. Recent advances in antibody generation technologies, along with high content screening are allowing us to generate unique antibody biological modulators that can be used to interrogate this complex cellular biology. This will allow for the identification of highly specific molecules that can alter cell biology in very precise ways, leading to new classes of therapeutics.
Michael Naso, Ph.D. is an Associate Director at Janssen Research and Development of Johnson and Johnson. He leads the Target Biology group within the Biologics Research department in the Biotechnology Center of Excellence. The focus of his group is to identify and validate novel targets, pathways and mechanisms for therapeutic intervention, and the discovery of antibody modulators for lead identification. Michael’s team supports all therapeutic areas within Janssen R&D, and has helped bring numerous lead candidates forward for early development. Michael received his Ph.D. from Thomas Jefferson University in Philadelphia, PA, in the department of Biochemistry and Molecular Biology, and has been with Johnson and Johnson for over 12 years.

The Antibody & Protein Therapeutics Conference strives to connect representatives from big pharma, academic institutions and government research labs to present data and case studies on key topics such as antibody drug conjugates, bispecific antibodies and overcoming the blood-brain barrier. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Michael Naso, Janssen to Present at Antibody & Protein Therapeutics Manufacturing on October 24-25 in San Diego, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today